Aspira Womens Health Inc (AWH)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CEO:
Valerie Barber Palmieri
Employees:
43
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX 78738
512-519-0400

Aspira Women's Health Inc. engages in the provision of bio-analytic and diagnostic services. It offers pelvic mass assessment, serum testing, and ovarian mass testing. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Data derived from most recent annual or quarterly report
Market Cap 57.633 Million Shares Outstanding112.127 Million Avg 30-day Volume 1.04 Million
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue16.1877 Debt to Equity0.1558 EBITDA-35.68 Million
Price to Book Value5.3669 Operating Margin-498.7654 Enterprise Value93.23 Million
Current Ratio4.854 EPS Growth0 Quick Ratio4.56
1 Yr BETA 1.7469 52-week High/Low 5.96 / 0.32 Profit Margin-485.6429
Operating Cash Flow Growth-95.9789 Altman Z-Score-16.8314 Free Cash Flow to Firm -25.759 Million
Earnings Report2022-08-11
View SEC Filings from AWH instead.

View recent insider trading info

Funds Holding AWH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AWH BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-07:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-02:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-05-18:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2022-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-23:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-05:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-06-23:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-05-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    142 Thousand total shares from 2 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SANDFORD NICOLE PRESIDENT AND CEO

    • Officer
    • Director
    5,000 2022-06-01 6

    PALMIERI VALERIE BARBER EXECUTIVE CHAIR

    • Officer
    • Director
    267,088 2022-05-16 1

    LAFRANCE JAMES T

    • Director
    606,434 2022-03-31 1

    JORDAN VERONICA GH

    • Director
    455,152 2022-03-31 1

    BEECHEY ROBERT HARRY CHIEF FINANCIAL OFFICER

    • Officer
    150,000 2022-03-31 1

    FRALICK CELESTE RACHELLE

    • Director
    99,671 2022-03-31 2

    COCOZZA NANCY G

    • Director
    128,632 2021-03-19 0

    SCHREIBER DAVID

    • Director
    171,521 2021-03-19 0

    BROOKS SANDRA ELAINE

    • Director
    14,728 2021-03-19 0

    FEINBERG LARRY N

    ORACLE PARTNERS LP

    • SHAREHOLDERSHAREHOLDER
    No longer subject to file 2020-07-09 0

    SCHULER JACK W

    25,394,517 2020-07-01 0

    BURNS JAMES S

    • Director
    473,461 2020-06-05 0

    SCHULER HENRI GEORGE

    14,494,639 2019-06-28 0

    PALMIERI VALERIE BARBER PRESIDENT AND CEO

    PALMIERI VALERIE BARBER PRESIDENT AND CEO

    • Officer
    • Director
    0 2019-03-26 1

    SEVERINGHAUS CARL

    • Director
    282,296 2018-04-13 0

    FERRARA FRED CHIEF OPERATING OFFICER

    • Officer
    0 2018-04-13 0

    FEINBERG LARRY N

    ORACLE PARTNERS LP

    ORACLE TEN FUND MASTER, LP

    ORACLE INSTITUTIONAL PARTNERS L P

    ORACLE ASSOCIATES LLC

    ORACLE INVESTMENT MANAGEMENT INC

    • 10% Owner
    • * SEE REMARKS* SEE REMARKS* SEE REMARKS* SEE REMARKS* SEE REMARKS* SEE REMARKS
    9,825,289 2017-08-31 0

    SCHOEN ERIC SVP FINANCE & CAO

    • Officer
    0 2017-03-23 0

    RODDY PETER S

    • Director
    195,555 2016-03-17 0

    MUNROE DONALD G SVP BUSINESS DEVELOPMENT & CSO

    • Officer
    0 2016-03-17 0

    BRADLEY THOMAS A EVP & CFO

    • Officer
    8,050 2016-02-10 0

    WEINHOFF SAMUEL J

    • Director
    41,825 2016-02-08 0

    DUPONT WESLEY D EVP & GENERAL COUNSEL

    • Officer
    203,488 2016-02-08 0

    CARMILANI SCOTT A PRESIDENT, CEO AND CHAIRMAN

    • Officer
    • Director
    1,353,422 2016-02-08 0

    GAUTHIER JOHN J EVP & CIO

    • Officer
    66,152 2016-02-08 0

    BAUZON HOLLY B VP MANAGED MARKETS

    • Officer
    0 2015-07-06 0

    MILLER LAURA ANN SVP SALES & CUST EXPERIENCE

    • Officer
    0 2015-02-13 0

    GOGGIN ROBERT ST LEGER

    • Director
    283,289 2014-12-19 0

    MCLAIN THOMAS H PRESIDENT & CEO

    • Officer
    0 2014-03-27 0

    SACCO MARIAN E SVP SALES & MARKETING AND CCO

    • Officer
    0 2014-03-27 0

    VARMA ERIC

    • Director
    23,000 2014-03-27 0

    FEINBERG LARRY N

    ORACLE PARTNERS LP

    ORACLE TEN FUND MASTER, LP

    ORACLE ASSOCIATES LLC

    ORACLE INVESTMENT MANAGEMENT INC

    • 10% Owner
    • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
    7,139,960 2013-12-19 0

    HUEBNER BRUCE A

    • FORMER DIRECTOR
    No longer subject to file 2013-12-12 0

    WALLEN WILLIAM C

    • FORMER DIRECTOR
    No longer subject to file 2013-12-12 0

    CREECH WILLIAM B. VP, SALES AND MARKETING

    • Officer
    30,137 2013-11-20 0

    SCHWARTZ ERIC S

    • Director
    35,158 2013-11-06 0

    DE SAINT-AIGNAN PATRICK

    • Director
    7,820 2013-05-24 0

    HAMILTON JOHN F

    • FORMER DIRECTOR
    No longer subject to file 2013-03-21 0

    PAGE GAIL S CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2012-03-22 0

    KOHLI ASHISH VP OF CORPORATE STRATEGY

    • Officer
    13,500 2011-09-15 0

    FUNG ERIC T S.V.P & C.S.O

    • Officer
    52,471 2011-06-09 0

    GARDINER SANDRA VP & CHIEF FINANCIAL OFFICER

    • Officer
    24,000 2011-03-18 0

    TRAN JOHN H. VP, FINANCE & CAO

    • Officer
    0 2010-03-19 0

    SENNOTT JOHN LANGTON JR EVP, CHIEF CORP. STRAT OFFICER

    • Officer
    13,452 2009-11-19 0

    ALEXANDER STILES BARBARA

    • Director
    2,000 2009-08-24 0

    RATHMANN JAMES L

    • Director
    0 2008-10-28 0

    YOUNG JOHN A

    • Director
    0 2008-10-28 0

    DALAL RAJEN

    • Director
    0 2008-10-28 0

    CONWAY KENNETH J

    • Director
    0 2008-10-28 0

    PHRONESIS PARTNERS L P

    WIGGINS JAMES

    • 10% Owner
    982,222 2008-08-26 0

    TAYLOR RICHARD G INTERIM CFO

    • Officer
    0 2008-08-26 0

    ZHOU QUN INTERIM CFO

    • Officer
    0 2008-07-18 0

    SHORTER SIMON C. VP, CORP BUSINESS DEVELOPMENT

    • Officer
    0 2008-07-18 0

    BRUNER JUDY

    • Director
    35,500 2007-09-13 0

    CALLAGHAN MICHAEL J

    • Director
    30,500 2007-09-13 0

    LUNDY STEVE SENIORVP-SALES & MKTG

    • Officer
    0 2007-05-16 0

    SULLIVAN WILLIAM C VP-CORPORATE OPERATIONS

    • Officer
    277,500 2007-04-26 0

    YOUNG DEBRA A VP-FINANCE & CFO

    • Officer
    225,000 2007-04-26 0

    DILLARD JOAN H SVP & CFO

    • Officer
    35,333 2007-02-26 0

    JODOIN RICHARD E PRES, AWAC(US)&NEWMARKETUND.

    • Officer
    22,334 2007-02-15 0

    MERRYWEATHER JAMES P EVP, SALES & MARKETING

    • Officer
    100,000 2006-06-07 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SANDFORD NICOLE - Director - Officer PRESIDENT AND CEO

    2022-06-01 17:26:04 -0400 2022-06-01 A 5,000 a 5,000 direct

    SANDFORD NICOLE - Director - Officer PRESIDENT AND CEO

    2022-05-17 17:02:01 -0400 2022-05-16 P 98,000 $0.76 a 136,160 direct -5.1724 -27.5862 0.0 1 -27.5862 6

    PALMIERI VALERIE BARBER - Director - Officer EXECUTIVE CHAIR

    2022-05-18 09:22:05 -0400 2022-05-16 P 43,994 $0.57 a 267,088 direct -5.1724 -27.5862 0.0 1 -27.5862 6

    SANDFORD NICOLE - Director - Officer PRESIDENT AND CEO

    2022-05-03 16:37:20 -0400 2022-05-02 A 5,000 a 5,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 22:15:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 21:45:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 21:15:04 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 20:45:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 20:15:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 19:45:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 19:15:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 18:45:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 18:15:04 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 17:45:04 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 17:15:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 16:45:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 16:15:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 15:45:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-23 15:15:03 UTC -18.5833 20.1533 15000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-22 22:15:03 UTC -18.7876 20.3576 50000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-22 21:45:03 UTC -18.7056 20.2756 50000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-22 21:15:03 UTC -18.7056 20.2756 50000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-22 20:45:03 UTC -19.2924 20.8624 50000
    ASPIRA WOMEN'S HEALTH INC AWH 2022-06-22 20:15:03 UTC -19.2924 20.8624 50000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund AWH -27154.0 shares, $-32856.34 2022-01-31 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund AWH -8899.0 shares, $-9254.96 2022-03-31 N-PORT

    Elevate your investments